# Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy

> **NCT06839443** · — · RECRUITING · sponsor: **Centro Hospitalar de Lisboa Central** · enrollment: 100 (estimated)

## Conditions studied

- Hidroxicloroquine Intake

## Interventions

- **DIAGNOSTIC_TEST:** Retinopathy group
- **DIAGNOSTIC_TEST:** Control group

## Key facts

- **NCT ID:** NCT06839443
- **Lead sponsor:** Centro Hospitalar de Lisboa Central
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-04-20
- **Final completion:** 2025-06-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06839443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06839443, "Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06839443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*